Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Ming Bioventures
AddedFeb 15, 2024
UpdatedJul 16, 2026
Ming Bioventures

Ming Bioventures

Operating

Ming Bioventures: A Suzhou-based financial firm specializing in innovative medical venture capital.

Location
Suzhou, Jiangsu, CN
Founded
2018
Firm
Compare
Portfolio
Employees

Ming Bioventures is a professional venture capital institution

focusing on innovative medicines, medical devices & new diagnostics.

Ming Bioventures - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments4
Current Portfolio Count3
Total Portfolio Exits0

Top Investment Stages

Angel1 (25.0%)
Seed1 (25.0%)
Series A1 (25.0%)
Series B1 (25.0%)

Stage Mix

Angel 25%Seed 25%Series A 25%Series B 25%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Innovo Therapeutics logo

Innovo Therapeutics

Tavotek Biotherapeutics logo

Tavotek Biotherapeutics

NuProbe logo

NuProbe

Ming Bioventures - Similar Investment Firms

BioVenture logo

BioVenture

bioventure.com.cn

YuanMing Capital logo

YuanMing Capital

Ming capital logo

Ming capital

Suzhou Science And Technology Ventures logo

Suzhou Science And Technology Ventures

Chuangyuan Venture Capital logo

Chuangyuan Venture Capital

Zhangjiagang Jinmao Venture Capital logo

Zhangjiagang Jinmao Venture Capital

Suzhou Xiangtang Venture Capital logo

Suzhou Xiangtang Venture Capital

Frontline BioVentures logo

Frontline BioVentures

Minyin International logo

Minyin International

SBI & TH Venture Capital Enterprise logo

SBI & TH Venture Capital Enterprise

Inbio Ventures logo

Inbio Ventures

Pathfinder Venture Capital Funds logo

Pathfinder Venture Capital Funds

MedVenture Partners logo

MedVenture Partners

MedVenture Associates logo

MedVenture Associates

Vinno Capital logo

Vinno Capital

Ming Bioventures - Classification

NAICS
  • 520000Finance and Insurance
SIC
  • 6000Depository Institutions